Browse All Treatments

Showing 1856 records.


Page 51 of 186 1 49 50 51 52 53 186
Order by:
SurvivalPatientsToxicityTreatmentHospitalCountryDate
50117.6 monthsAdvanced metastatic colorectal cancer4ChemotherapyKyoto University Graduate School of MedicineJapanFeb 2004
Treatment Details: Patients: This phase II study involved 56 patients with advanced/metastatic colorectal cancer. Treatment: Treatment consisted of the chemotherapy drug, capecitabine (xeloda). ... read more
50217.6 monthsAdvanced castration-resistant prostate cancer 5ChemotherapyUniversity of Southern California Norris Comprehensive Cancer CenterUnited StatesAug 2013
Treatment Details: Patients: This phase 3 study involved advanced castration-resistant prostate cancer patients who were divided into two separate treatment groups. Group A had 496 patients with a ... read more
50317.6 monthsGBM3RadiationUCLA School of MedicineUnited StatesNov 2007
Treatment Details: Patients: This phase I study involved 33 patients with glioblastoma multiforme. The median age of these patients was 51, ranging from 23-72 years old. Twenty-one patients were m... read more
50417.6 monthsMetastatic prostate cancer4Chemotherapy, Biologic therapyDuke Comprehensive Cancer CenterUnited StatesOct 2008
Treatment Details: Patients: This phase I-II study involved 31 patients with metastatic, castration-resistant prostate cancer. The median age was 68, ranging from 50 to 81 years of age. Most (81%) ... read more
50517.5 monthsStage IIIA-N2 NSCLC4Chemotherapy, Radiation, SurgeryUniversity Hospital GhentBelgiumMar 2007
Treatment Details: Patients: This study involved 579 patients with stage IIIA-N2 non-small cell lung cancer. Of these, 74% were men and 26% were women. The median age was 61 years. Treatment: ... read more
50617.5 monthsAdvanced NSCLC3Biologic therapyMassachusetts General Hospital Cancer CenterUnited StatesMay 2008
Treatment Details: Patients: This phase II study involved 31 patients with advanced non-small-cell lung cancer. These patients also had a mutation in a gene called EGFR. The median age was 62, ran... read more
50717.5 monthsMetastatic or primary breast cancer4ChemotherapyUniversity Hospital of ViennaAustriaAug 2002
Treatment Details: Patients: This Phase I/II trial involved 33 women with metastatic or primary breast cancer. Treatment: The treatment consisted of two drugs – epidoxorubicin and docetaxel (taxo... read more
50817.5 monthsMetastatic rcc4ImmunotherapyBeth Israel Deaconess Medical CenterUnited StatesJan 2005
Treatment Details: Patients: This Phase III study involved a total of 192 patients with metastatic renal cell carcinoma. Patients were divided into two groups of 96 patients each. Each group was ad... read more
50917.5 monthsMetastatic Melanoma5Biologic therapy, ImmunotherapyDana-Farber Cancer InstituteUnited StatesNov 2014
Treatment Details: Patients: This phase 2 study involved metastatic melanoma patients who were divided into two separate treatment groups. Group A consisted of 123 patients with a median age of 61 ... read more
51017.5 monthsNHL5Chemotherapy, Hormone, Biologic therapyMemorial Sloan-Kettering Cancer CenterUnited StatesMar 2015
Treatment Details: Patients: This phase 2 study involved 30 elderly relapsed or refractory diffuse large B-cell lymphoma patients who were previously treated. The median patient age was 76 years (r... read more
Page 51 of 186 1 49 50 51 52 53 186